Abstract
Cardiovascular disease (CVD) is common among patients with cancer, potentially due to overlapping risk factors such as diabetes, obesity, tobacco abuse, etc. While underlying systemic inflammation appears to be a common driver for both disease processes, a significant burden of CVD also appears to stem from anti-cancer therapies. As the paradigm of cancer care continues to evolve from purely disease-focused to more patient-centered, there is a growing emphasis on developing strategies for the early diagnosis and treatment of disease and treatment-related complications such as CVD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
